These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31383575)

  • 1. Safe Use of Radium-223 Dichloride (
    Aro JL; Dinning SI; Leung EY; Zuckier LS
    J Med Imaging Radiat Sci; 2019 Dec; 50(4S1):S36-S40. PubMed ID: 31383575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [
    Yang Y; Alencar LMR; Pijeira MSO; Batista BDS; França ARS; Rates ERD; Lima RC; Gemini-Piperni S; Santos-Oliveira R
    Drug Deliv; 2022 Dec; 29(1):186-191. PubMed ID: 35191342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose estimation after a mixed field exposure: Radium-223 and intensity modulated radiotherapy.
    Bastiani I; McMahon SJ; Turner P; Redmond KM; McGarry CK; Cole A; O'Sullivan JM; Prise KM; Ainsbury L; Anderson R
    Nucl Med Biol; 2022; 106-107():10-20. PubMed ID: 34968973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radionuclide therapy for osseous metastases in prostate cancer.
    Abi-Ghanem AS; McGrath MA; Jacene HA
    Semin Nucl Med; 2015 Jan; 45(1):66-80. PubMed ID: 25475380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micellar solution of [
    Pijeira MSO; Gomes-da-Silva NC; Ricci-Junior E; Alencar LMR; İlem-Özdemir D; Cavalcanti ADS; Machado DE; Perini JA; Santos-Oliveira R
    Int J Pharm; 2024 Mar; 652():123765. PubMed ID: 38195032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of age on radium-223 distribution and an evaluation of molecular imaging surrogates.
    Jiang W; Ulmert D; Simons BW; Abou DS; Thorek DLJ
    Nucl Med Biol; 2018; 62-63():1-8. PubMed ID: 29800797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Single Photon Emission Computed Tomography of Alpha Particle-Emitting Radium-223.
    Abou DS; Rittenbach A; Tomlinson RE; Finley PA; Tsui B; Simons BW; Jha AK; Ulmert D; Riddle RC; Thorek DLJ
    Cancer Biother Radiopharm; 2020 Sep; 35(7):520-529. PubMed ID: 32182119
    [No Abstract]   [Full Text] [Related]  

  • 8. Decreasing undesirable absorbed radiation to the intestine after administration of radium-223 dichloride for treatment of bone metastases.
    Ogawa K; Higashi T; Mishiro K; Wakabayashi H; Shiba K; Odani A; Kinuya S
    Sci Rep; 2020 Jul; 10(1):11917. PubMed ID: 32681007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nano-hydroxyapatite radiolabeled with radium dichloride [
    Gemini-Piperni S; Ricci-Junior E; İlem-Özdemir D; da Silva Batista B; Alencar LMR; Rossi AM; Santos-Oliveira R
    Colloids Surf B Biointerfaces; 2023 Mar; 223():113174. PubMed ID: 36746067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radium-223 for the treatment of bone metastases in castration-resistant prostate cancer: when and why.
    Gallicchio R; Mastrangelo PA; Nardelli A; Mainenti PP; Colasurdo AP; Landriscina M; Guglielmi G; Storto G
    Tumori; 2019 Oct; 105(5):367-377. PubMed ID: 31096849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radium-223 dichloride in clinical practice: a review.
    Florimonte L; Dellavedova L; Maffioli LS
    Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1896-909. PubMed ID: 27121689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosing, administration, and safety of radium-223: How I do it.
    Dan TD; Doyle L; Raval AJ; Pridjian A; Gomella LG; Den RB
    Can J Urol; 2016 Jun; 23(3):8301-5. PubMed ID: 27347625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New treatment option: 223Ra chloride, the first approved unsealed α-emitting radiopharmaceutical.
    Colletti PM
    Clin Nucl Med; 2013 Sep; 38(9):724-5. PubMed ID: 23867617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radium-223 chloride: Extending life in prostate cancer patients by treating bone metastases.
    Wissing MD; van Leeuwen FW; van der Pluijm G; Gelderblom H
    Clin Cancer Res; 2013 Nov; 19(21):5822-7. PubMed ID: 24052017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA approves radiopharmaceutical for metastatic prostate cancer.
    Cancer Discov; 2013 Jul; 3(7):OF1. PubMed ID: 23847352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural Analysis of Cancer Cells Treated with the Radiopharmaceutical Radium Dichloride ([
    Diniz Filho JFS; de Barros AODS; Pijeira MSO; Ricci-Junior E; Midlej V; Baroni MPMA; Dos Santos CC; Alencar LMR; Santos-Oliveira R
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radium Ra 223 dichloride injection: U.S. Food and Drug Administration drug approval summary.
    Kluetz PG; Pierce W; Maher VE; Zhang H; Tang S; Song P; Liu Q; Haber MT; Leutzinger EE; Al-Hakim A; Chen W; Palmby T; Alebachew E; Sridhara R; Ibrahim A; Justice R; Pazdur R
    Clin Cancer Res; 2014 Jan; 20(1):9-14. PubMed ID: 24190979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radium Ra 223 dichloride in castration-resistant prostate cancer.
    Joung JY; Ha YS; Kim IY
    Drugs Today (Barc); 2013 Aug; 49(8):483-90. PubMed ID: 23977665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radium 223 dichloride: a multidisciplinary approach to metastatic castration-resistant prostate cancer.
    Borsò E; Boni G; Galli L; Ricci S; Farnesi A; Mazzarri S; Cianci C; Mariani G; Falcone A
    Future Oncol; 2015; 11(2):323-31. PubMed ID: 25075962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radium-223 dichloride: a novel treatment option for castration-resistant prostate cancer patients with symptomatic bone metastases.
    McGann S; Horton ER
    Ann Pharmacother; 2015 Apr; 49(4):469-76. PubMed ID: 25573268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.